Navigation Links
Boston Healthcare Appoints Adam Barak as Vice President Enhancing Its International Pricing and Reimbursement Capability
Date:10/28/2008

Boston Healthcare grows to meet increasing global demand for health

economics and market access support

BOSTON, Oct. 28 /PRNewswire/ -- Boston Healthcare Associates, Inc. today announced the appointment of Adam Barak as Vice President.

Mr. Barak brings 16 years of pricing and reimbursement experience, including the development of global pricing and reimbursement strategies for drugs, medical devices, and diagnostics in a wide range of therapeutic areas including oncology, pulmonary medicine, gastroenterology, cardiovascular medicine, neurology, and critical care.

"Adam's appointment demonstrates Boston Healthcare's continued commitment to expanding the scope and reach of our services," said Joseph Ferrara, President of Boston Healthcare. "His wealth of experience in pricing and reimbursement will strengthen our position internationally, and provide the expertise and leadership we need to serve our clients more effectively worldwide. Adam is a strong addition to the executive management team and an asset to our global strategy."

Mr. Barak joined GlaxoWellcome's International Pricing & Reimbursement division in 1996. In 1997, Mr. Barak became Head of European Pricing, managing the regional function and developing international pricing strategies for four of the seven GlaxoWellcome therapy areas, including European pricing strategies for CNS, cardiovascular, oncology, anesthesiology and diabetes drugs. In 2001, Mr. Barak joined Oxford GlycoSciences as International Pricing and Reimbursement Manager, developing global pricing, reimbursement, and market access strategy for Zavesca, the company's first pharmaceutical launch. In 2002, Mr. Barak established his own consultancy, ABPPC Ltd, and formed a global network of consultants that provide the international pharmaceutical and health care community with specialized support for pricing, reimbursement, and market access. The network covers 22 countries, and is repres
'/>"/>

SOURCE Boston Healthcare Associates, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Boston Scientific Announces Results for Third Quarter Ended September 30, 2008
2. Boston Scientific Provides Comments Reinforcing Strength of Its Balance Sheet
3. Boston Scientific Provides Update on Involuntary Selling of Its Stock by Co-Founders
4. Video: Boston Scientific Announces FDA Approval of Second-Generation TAXUS(R) Liberte(R) Drug-Eluting Stent
5. Boston Scientific Announces FDA Approval of TAXUS(R) Express2(TM) Atom(TM) Stent System, First Drug-Eluting Stent For Small Vessels
6. Boston Scientific to Participate in UBS Global Life Sciences Conference
7. Boston Scientific Announces Court Decision
8. IBC Life Sciences Kicks Off the 13th Annual Drug Discovery & Development of Innovative Therapeutics World Congress in Boston, Massachusetts
9. InNexus Biotechnology CEO and Chief Scientific Officer to Present at IBCs Annual World Congress Conference in Boston on Aug 6th
10. NorthPoint Domain and Boston Medical Center Partner to Apply Advanced Patient Engagement Instruments to Pioneering Cardiac Robotic Surgery Program
11. TechCFO Adds Gary Strickland as Partner in Boston Office
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... ... 01, 2015 , ... A newly launched business plan contest will ask startup ... innovation in life sciences R&D. The Pistoia Alliance President’s Startup Challenge 2015 will see ... a period of expert mentorship from a senior industry figure drawn from the Pistoia ...
(Date:7/1/2015)... IN (PRWEB) , ... July 01, 2015 , ... Apex ... 2015 BIO International Convention in Philadelphia, PA. , The presentation took place ... and outlined the plans for the development of APX3330 for the treatment of pancreatic ...
(Date:7/1/2015)... NEW YORK , July 1, 2015 /PRNewswire/ ... G ), a global leader in designing, ... the Aecus Innovation Award in recognition of their ... operational efficiencies in UCB,s global business services (GBS) ... acknowledge service providers and clients that work together ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... to take part in the first half of “Integrative Biotechnology,” an applied biotechnology ... established in summer 2014, this course combines students from both universities and is ...
Breaking Biology Technology:Pistoia Alliance Launches Startup Challenge 2Pistoia Alliance Launches Startup Challenge 3Apex Therapeutics Presented Company Overview at This Year’s BIO International Convention in Philadelphia, PA 2UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 2UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 3UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 4UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 5Rivier University and Beijing City University Academic and Cultural Exchanges Begin 2
... advanced biomaterials company, today announced two presentations at the ... Chengdu, China. ETEX will highlight their vertebral augmentation and ... Head of R&D of ETEX Corporation, will deliver an ... Vertebral Augmentation " during Rapid Fire Session (R3), June ...
... College (BHCC) celebrated the graduation of 18 students ... a ceremony that also marked the 20th anniversary ... between BHCC,s Workforce Development Center, the Just-A-Start Corporation ... Cambridge residents who complete – at no cost ...
... 2012 Rhythm announced today the results of a ... ghrelin agonist for the treatment of diabetic gastroparesis. The ... patients with diabetic gastroparesis. The findings were presented at ... The Phase 1b clinical trial was a ...
Cached Biology Technology:ETEX Corporation to present at the 9th World Biomaterial Congress 2Bunker Hill Community College Holds Biomedical Careers Graduation Ceremony 2Rhythm Announces Phase 1b Results for Ghrelin Prokinetic RM-131 for Diabetic Gastroparesis 2
(Date:6/29/2015)... Research and Markets( http://www.researchandmarkets.com/research/zj7h4f/latin_america ... America Biomedical Sensors Market - Growth, Trends & Forecasts ... Latin America Biomedical Sensors market is estimated at $0.65 ... the period 2014-2020 The near future will ... formulation of each individual. These sensors can be set ...
(Date:6/25/2015)... June 25, 2015  Imagine a tool specifically designed ... healthier, happier life. That,s exactly what USANA,s True ... The cutting-edge, portable health program provides a personalized approached ... help improve your lifestyle and nutrition. ... gala Wednesday night, USANA,s THA was honored with the ...
(Date:6/24/2015)... YORK , June 24, 2015 This ... market, over the next six years. It contains an ... the industry, along with their impact from the short, ... It also discusses the industry, market, and technology trends ... that the need of concerned authorities to efficiently manage ...
Breaking Biology News(10 mins):Latin America Biomedical Sensors Market Report 2015-2020 2@USANAinc's Personalized Nutrition Program Wins Industry Innovation Award 2Automatic Identification System Market by Class, by Platform, by Application and by Geography - Global Forecasts & Analysis to 2014 - 2020 2
... from the National Institute of Standards and Technology ... Ground have developed reliable methods based on DNA ... anthrax spores after prolonged storage. The techniques and ... reference standard for anthrax detection and decontamination. ...
... 2008Clinical researchers at Scottsdale Healthcare and TGen today announced ... for patients battling cancer. The Phase I ... Meeting of the American Association for Cancer Research by ... carcinoma (BCC) and pancreatic cancer. The Arizona trials were ...
... is available in French . , ... Management, the private bankers Lombard Odier Darier Hentsch & ... at EPFL dedicated to sustainable development. The chair is ... fundamental and social sciences in the environmental domain. ...
Cached Biology News:NIST, Army researchers pave the way for anthrax spore standards 22 new therapies show promise for cancer patients 22 new therapies show promise for cancer patients 3EPFL Research Day 2008, in the presence of Al Gore 2EPFL Research Day 2008, in the presence of Al Gore 3
ANTI MYCOBACTERIUM TUBERCULOSIS...
IMAGEQUANT 100 WKSTN, 1 EA. Category: ImageQuant CCD Imagers....
IMAGEQUANT 300 IQTL, 1 EA. Category: ImageQuant CCD Imagers....
Recombinant Feline IL-12/IL-23 p40 (C-Terminus), CF...
Biology Products: